A recent meta-analysis following Prisma guidelines emphasizes the fact that high IL-17A quantities were correlated with poor prognosis in cancer and notably in colorectal cancer but the impact of high Th17 cell frequencies is very controversial and depends on the cancer type [42]. The gene discussed is IL17A; the disease is cancer.